logo
Microsoft says its new health AI beat doctors in accurate diagnoses by a mile

Microsoft says its new health AI beat doctors in accurate diagnoses by a mile

Microsoft said its medical AI system diagnosed cases more accurately than human doctors by a wide margin.
In a blog post published on Monday, the tech giant said its AI system, the Microsoft AI Diagnostic Orchestrator, diagnosed cases four times as accurately as a group of experienced physicians in a test.
Microsoft's study comes as AI tools rapidly make their way into hospitals and clinics, raising questions about how much of medicine can or should be automated and what role doctors will play as diagnostic AI systems get more capable.
The experiment involved 304 case studies sourced from the New England Journal of Medicine. Both the AI and physicians had to solve these cases step by step, just like they would in a real clinic: ordering tests, asking questions, and narrowing down possibilities.
The AI system was paired with large language models from tech companies like OpenAI, Meta, Anthropic, and Google. When coupled with OpenAI's o3, the AI diagnostic system correctly solved 85.5% of the cases, Microsoft said.
By contrast, 21 practicing physicians from the US and UK — each with five to 20 years of experience — averaged 20% accuracy across the completed cases, the companyadded. In the study, the doctors did not have access to resources they might typically tap for diagnostics, including coworkers, books, and AI.
The AI system also solved cases "more cost-effectively" than its human counterparts, Microsoft said.
"Our findings also suggest that AI reduce unnecessary healthcare costs. US health spending is nearing 20% of US GDP, with up to 25% of that estimated to be wasted," it added.
"We're taking a big step towards medical superintelligence," said Mustafa Suleyman, the CEO of Microsoft's AI division, in a post on X.
He added that the cases used in the study are "some of the toughest and most diagnostically complex" a physician can face.
Suleyman previously led AI efforts at Google.
Microsoft did not respond to a request for comment from Business Insider.
Will AI replace doctors?
Microsoft said in the blog post that AI "represents a complement to doctors and other health professionals."
"While this technology is advancing rapidly, their clinical roles are much broader than simply making a diagnosis. They need to navigate ambiguity and build trust with patients and their families in a way that AI isn't set up to do," Microsoft said.
"Clinical roles will, we believe, evolve with AI," it added.
Tech leaders like Microsoft cofounder Bill Gates have said that AI could help solve the long-standing shortage of doctors.
"AI will come in and provide medical IQ, and there won't be a shortage," he said on an episode of the "People by WTF" podcast published in April.
But doctors have told BI that AI can't and shouldn't replace clinicians just yet.
AI can't replicate physicians' presence, empathy, and nuanced judgment in uncertain or complex conditions, said Dr. Shravan Verma, the CEO of a Singapore-based health tech startup.
Chatbots and AI tools can handle the first mile of care, but they must escalate to qualified professionals when needed, he told BI last month.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HyperStrong Accelerates APAC Expansion Through Strategic Cooperation with Alpina to Advance Integrated Charging + Storage Development
HyperStrong Accelerates APAC Expansion Through Strategic Cooperation with Alpina to Advance Integrated Charging + Storage Development

Yahoo

time43 minutes ago

  • Yahoo

HyperStrong Accelerates APAC Expansion Through Strategic Cooperation with Alpina to Advance Integrated Charging + Storage Development

BEIJING, July 2, 2025 /PRNewswire/ -- HyperStrong, a global leader in energy storage system integration, signed a strategic Memorandum of Understanding (MoU) with Singapore-based energy infrastructure developer Alpina on 29 June, to jointly advance the development of integrated charging and storage infrastructure across the Asia-Pacific region. Under the MoU, HyperStrong will supply 5,000 sets of charging plus storage integrated units to Alpina from 2025 to 2027, strengthening efforts to meet the surging demand for EV charging infrastructure in fast-growing APAC markets. The new-generation all liquid-cooled integrated units to be deployed under this collaboration features built-in semi-solid-state batteries, AI-driven early warning systems, and multi-layer fire safety capabilities including detection, suppression, and prevention — ensuring intrinsic safety. It also supports full-station energy sharing, DC/AC coupling, and renewable energy integration with PV and wind power. It enables 2-5 times more charging terminals under the same transformer capacity and improves site-level charging capacity by 40%–80%, significantly delaying the need for costly grid upgrades. The solution supports multiple business models including peak shaving, demand control, capacity expansion, virtual power plants, reactive power regulation, and backup power — driving diversified revenue streams. Low Siong Yong, Executive Chairman and CEO of Alpina, stated: "With the rapid adoption of EVs in Singapore and Southeast Asia, demand for efficient, intelligent, and compliant storage + charging solutions is growing rapidly. We are delighted to partner with HyperStrong, a global storage technology leader, to unlock more value from storage in urban energy systems." Mr. Kevin Changbin Qiu, Senior Vice President of HyperStrong International, commented: "HyperStrong has deep technical strengths in system integration, intelligent manufacturing, and lifecycle services. This partnership with Alpina is a significant milestone in our APAC strategy, and we look forward to jointly building future-ready energy infrastructure to support the region's low-carbon transition." This collaboration is a strategic milestone for HyperStrong, not only establishing a presence in Singapore but also serving as a launchpad for further market penetration in the Asia-Pacific region. It also represents a successful application of HyperStrong's "Energy Storage + X" strategy and a benchmark for integrating flexible, intelligent technologies in urban energy systems. By addressing growing demand for fast-charging infrastructure, the partnership contributes to regional decarbonization and sustainable mobility. Looking ahead, HyperStrong will continue driving global deployment of its "Energy Storage + X" solutions through technological innovation and cross-regional collaboration, contributing to the realization of global carbon neutrality goals and the broader energy transition. About HyperStrong Beijing HyperStrong Technology Co., Ltd. ("HyperStrong", is a global leading energy storage system (ESS) integrator and service provider. Founded in 2011, with more than 13 years of research and development, as well as experience garnered through more than 300 energy storage projects and more than 30GWh of deployment, HyperStrong offers a portfolio of ESS products and one-stop solutions for the full spectrum of utility-scale, commercial and industrial applications. Having built four smart manufacturing bases, three R&D centers, two testing labs and a global marketing center, HyperStrong empowers clients worldwide to achieve their energy transition and carbon neutrality goals. For more information about HyperStrong, visit: About Alpina Alpina Holdings Limited is headquartered in Singapore and was founded in 2003. The company was listed on the Singapore Exchange (SGX) in 2022. Alpina is an established specialist in providing Integrated Building Services (IBS), M&E Engineering Services (M&E), Alteration and Addition Works (A&A) for both public and private sector projects in Singapore, with a long operating history of over 20 years. For more information about Alpina, visit: View original content to download multimedia: SOURCE Beijing HyperStrong Technology Co., Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

New AI tool is better than doctors at diagnosing complicated medical issues, Microsoft says
New AI tool is better than doctors at diagnosing complicated medical issues, Microsoft says

Yahoo

timean hour ago

  • Yahoo

New AI tool is better than doctors at diagnosing complicated medical issues, Microsoft says

Microsoft said it is one step closer to 'medical superintelligence' after a new artificial intelligence (AI) tool beat doctors at diagnosing complex medical problems. Tech giants are racing to develop superintelligence, which refers to an AI system that exceeds human intellectual abilities in every way – and they're promising to use it to upend healthcare systems around the world. For the latest experiment, Microsoft tested an AI diagnostic system against 21 experienced physicians, using real-world case studies from 304 patients that were published in the New England Journal of Medicine, a leading medical journal. The AI tool correctly diagnosed up to 85.5 per cent of cases – roughly four times more than the group of doctors from the United Kingdom and the United States, who had between five and 20 years of experience. Related As AI reshapes patient care, human nurses are pushing back against its creeping influence The model was also cheaper than human doctors, ordering fewer scans and tests to reach the correct diagnosis, the analysis found. Microsoft said the findings indicate that AI models can reason through complex diagnostic problems that stump physicians, who specialise in their fields but are not experts in every aspect of medicine. However, AI 'can blend both breadth and depth of expertise, demonstrating clinical reasoning capabilities that, across many aspects of clinical reasoning, exceed those of any individual physician,' Microsoft executives said in a press release. 'This kind of reasoning has the potential to reshape healthcare'. Microsoft does not see AI replacing doctors anytime soon, saying the tools will instead help physicians automate some routine tasks, personalise patients' treatment, and speed up diagnoses. Microsoft's AI system made diagnoses by mimicking a doctor's process of collecting a patient's details, ordering tests, and eventually narrowing down a medical diagnosis. A 'gatekeeper agent' had information from the patient case studies. It interacted with a 'diagnostic orchestrator' that asked questions and ordered tests, receiving results from the real-world workups. Related Is AI going to steal your job? Probably not, new study finds The company tested the system with leading AI models, including GPT, Llama, Claude, Gemini, Grok, and DeepSeek. OpenAI's o3 model, which is integrated into ChatGPT, correctly solved 85.5 per cent of the patient cases, compared to an average of 20 per cent among the group of 21 experienced doctors. The researchers published their findings online as a preprint article, meaning it has not yet been peer-reviewed. Microsoft also acknowledged some key limitations, notably that the AI tool has only been tested for complicated health problems, not more common, everyday issues. Related AI to shape EU health policymaking without new rules The panel of doctors also worked without access to their colleagues, textbooks, or other tools that they might typically use when making diagnoses. 'This was done to enable a fair comparison to raw human performance,' Microsoft said. The company called for more real-world evidence on AI's potential in health clinics, and said it will 'rigorously test and validate these approaches' before making them more widely available.

Why Intel Growth Story May Be Hitting a Wall
Why Intel Growth Story May Be Hitting a Wall

Yahoo

timean hour ago

  • Yahoo

Why Intel Growth Story May Be Hitting a Wall

June 26 - Intel (NASDAQ:INTC) could be heading into tougher terrain as geopolitical tensions and new export rules weigh heavily on the chipmaker's China-reliant business. While the company continues to promote its AI and foundry ambitions under new CEO Lip-Bu Tan, its fundamental outlook remains fragile amid a shifting regulatory landscape. Taiwan's recent move to include Huawei and SMIC on its Strategic High-Tech Commodities Entity List marks another potential blow. The change effectively blocks the export of semiconductor products to firms without a special license, disrupting Intel's access to Huawei, a key PC customer in China. Huawei's MateBook lineup, powered by Intel Core Ultra processors, saw growing momentum in 2024, but future deliveries may now face delays or compliance hurdles. Warning! GuruFocus has detected 7 Warning Signs with INTC. Intel's dependence on China, where it derived about 29% of its 2024 revenue, primarily through its Client Computing Group (NASDAQ:CCG), exposes it to tightening U.S. and allied export controls. The CCG unit, which accounted for more than 60% of Intel's consolidated sales in Q1, remains a core earnings driver. But any shift in trade policy that restricts sales of mainstream PC chips, even indirectly, could weigh on results. The chip maker is also dealing with wider execution issues. Its combativeness into AI servers through the Gaudi platform lags behind the shark competitor Nvidia (NASDAQ:NVDA), and the enhanced suspension of Falcon Shores chips highlights execution remnants. Meanwhile, the capital requirements of Intel Foundry are high, and it is not completely clear how the solution will be adopted by external customers long-term. The action by Taiwan in July which evoked this move was an attempt to restrict its exports as part of the U.S attempt to restrict the Chinese access to advanced technologies. All these developments echo previous shocks, including the mid-2024 cancellation of Intel export licenses to Huawei that resulted in 30% plunges when its stock failed to meet results in China. There is relatively no response in the market yet, as Intel shares remained around $20 in spite of such accumulating risks. But analysts caution that this complacency will not be sustained. Having weak underlying principles, poor performance of its AI roadmap, and growing headwinds within the regulatory environment, the Intel stock might be subjected to the continuation of its decline. This article first appeared on GuruFocus. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store